Laboratorio Proagro Competitors and Similar CompaniesClear all

Laboratorio Proagro's competitors and similar companies include Antibiotice, Eagle Veterinary Technology, Vetoquinol and Recipharm Stockholm.

	Laboratorio Proagro Laboratorio Proagro is a laboratory of veterinary drugs for large and small animals.	Antibiotice Antibiotice is a pharmaceutical company.	Eagle Veterinary Technology Eagle Veterinary Technology (formerly known as Eagle Chemical) is a company that manufactures, develops, and sells animal healthcare products.	Vetoquinol Vetoquinol is a veterinary pharmaceutical company.	Recipharm Stockholm Recipharm Stockholm is a manufacturer and developer of drugs in pharmaceuticals for human and veterinary use.
Founding Date	Founding Date N/A	Founding Date 1955	Founding Date 1970	Founding Date 1993	Founding Date 2004
Type	Type Private	Type Private	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare drug development pharmacy veterinary	Tags Healthcare drug development pharmacy veterinary	Tags Healthcare distribution drug development pets pharmacy veterinary	Tags Healthcare drug development pharmacy veterinary	Tags Healthcare drug development pharmacy veterinary
Locations	Locations Rosario, AR HQ	Locations Iași, RO HQ Chișinău, MD Bucharest, RO Sremska Kamenica, RS Kyiv, UA	Locations Yesan-gun, KR HQ Seoul, KR	Locations Brisbane Airport, AU HQ Lavaltrie, CA Magny Vernois, FR Ismaning, DE Mumbai, IN Panighina, IT see more	Locations Älvsjö, SE HQ
Employees	Employees 647% increase	Employees 601	Employees N/A	Employees 781% decrease	Employees 134
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩41.7b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) kr219.5m (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩27b (FY, 2024)	Cost of goods N/A	Cost of goods kr145.8m (FY, 2020)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₩14.8b (FY, 2024)	Gross profit N/A	Gross profit kr73.8m (FY, 2020)
Net income	Net income N/A	Net income N/A	Net income ₩3.7b (FY, 2024)	Net income N/A	Net income (kr864.4k) (FY, 2020)